Method for the treatment of patients with purulent-necrotic diseases of the maxillofacial area

 

(57) Abstract:

The invention relates to medicine, namely to surgery. Provide external access to the focus of necrotic lesion and placed in the wound cavity napkin “Kreteks D” or napkin “Kreteks M” in the form of a hollow element, inside of which are placed end-to-end Winternitz drainage. It should be fastened together with a cleaning cloth to the skin wound, between the edges of the second stack is similar to the cloth forming the wound edges in a linear plane. Irradiated wound infrared laser in therapeutic doses through the drainage on the depth of the wound and on the edge of the wound for 5-8 minutes on each field, as well as applied transcutaneously to the carotid artery for 2-3 minutes daily until the end of the purulent discharge from the wound. Then hold the applique cloth Collex MEX region infiltrate with irradiation for 5-10 minutes until complete wound healing. The proposed method allows to reduce the time of stay of the patient in the hospital, to significantly improve the cosmetic effect, to exclude the possibility of complications.

The invention relates to medicine, for the treatment of patients with odontogenic inflammatory processes of maxillofacial area.

Treatment of HS early-treated areas of the face, persistent contraction of the masticatory muscles of the face and so on) in patients with phlegmon and abscess of oral and maxillofacial region is a very important issue of oral and maxillofacial surgery. In recent years in our country and abroad intensively developed dressings using different biologically active materials that enhance the reparative process in the wound.

There is a method of treatment of patients with purulent-necrotic processes of maxillofacial area, including laser therapy in children with nonspecific lymphadenitis of face and neck based on the use of low-intensity infrared laser radiation in a constant magnetic field - magnetic-laser therapy (MLT). A pronounced effect of IFL is implemented at the local level in irradiated tissues. (I. A. Pasewicz, A., Shargorodsky. Infrared low-intensity laser radiation in the diagnosis and complex treatment of acute nonspecific lymphadenitis of face and neck in children. //Dentistry. 1999. No. 2 - n-29-30).

The disadvantage is that this impact is not considered specific infectious process (microflora), the impact of short-term and limited (only the lymph nodes).

The disadvantage of this method is limited its application only to the mucosa of the oral cavity.

There is a method of treatment of patients with purulent wound process different localization with the use of laser energy and allogenic material in combination with conventional methods (surgery, antibiotics, etc). (C. S. Panteleev “Stimulation of regenerative processes in the wound with the use of allogeneic blood and energy of the laser radiation” thesis for the degree of Cand. the honey. of Sciences, Ufa, 2002, S. 3-10, prototype).

The disadvantage of this method is that it provides a satisfactory cosmetic effect required in the maxillofacial region, in addition, the use of allogenic biomaterial is not effective, as it results in a rapid washout of the wound, i.e., the loss of drug action through a small period of time.

Given the above, the authors of the task, aimed at eliminating these disadvantages, improving the efficiency of treatment by surgical intervention, accelerated removal of exudate from the wound cavity, which are provided by the use of complex fisiopatylogicas impact photophoresis drugs, immobilized in the gel, applied on a textile basis and hosted by the proposed method in the wound cavity, improved cosmetic result.

For this purpose, the method of treatment of patients with purulent-necrotic diseases of the maxillofacial area, including surgical treatment with the introduction of purulent-necrotic lesion of the bioactive material, the laser irradiation wounds proposed to implement external access to the focus of necrotic lesion, for example, a skin incision of 4-5 cm in the enclosed area at the lower pole of purulent-necrotic lesion, and be placed in the wound cavity napkin “Kreteks D” or napkin “Kreteks M” in the form of a hollow element, inside of which lay through Winternitz drainage. It should be fastened together with a cleaning cloth to the skin wound, between the edges of the second stack is similar to the cloth forming the wound edges in a linear plane, and the exposure of the wound to provide an infrared laser in therapeutic doses through the drainage on the depth of the wound and on the edge of the wound for 5-8 minutes on each field, as well as applied transcutaneously to the carotid artery for 2-3 minutes daily until the end of the purulent discharge from the wound, then hold the applique cloth Collex MEX” area in which to medicinal substance on the wound area and hour to clean it in the first phase of inflammation, that leads to earlier development of granulation in the wound healing without the formation of keloid scars.

The method is as follows.

Comprehensive therapy for all patients from the second day after the mandatory surgical treatment: opening purulent-necrotic lesion access to the focus and draining wounds polyamide tubes throughout the depth of the fiber space with preliminary treatment of the wound with antiseptic solutions. In the wound place the napkin “Kreteks M” (for more severe suppurative process place the napkin “Coltext”) with immobilized textile based metronidazolum or Dimexidum (respectively “Kreteks M”, “Kreteks D”) in the form of a hollow element, swirling around Winternitz drainage tube to improve outflow and prolonged drug exposure in the deeper parts of the wound. The wound edges form podlivaniem tissues between the upper and lower pole, keeping the linear plane. Laser therapy is for therapeutic scheme: after surgery, the effect of IR laser for 1-2 minutes to 10 mW at the wound area and for 4-6 minutes on the depth of the wound through the drainage tube taking into account the size of the wound, and tramvia lead to increased fibrinolytic activity, acceleration of the process of lysis of necrotic masses and improve microcirculation in the area of the pathological process.

During granulation, if necessary, possible replacement of drainage with subsequent continuation of the above treatment.

In the phase of scarring are applique skin wounds with cloth Collex MEX (Mexidol), through which is carried out photophoresis for 5-10 minutes until complete epithelialization.

Conducted inspection: radiographic methods, elektrovozoremontnyy neuromuscular apparatus, electromyographic studies, studying biopsies before and after treatment, and wound microflora content showed high efficiency of treatment with a good cosmetic result, against the backdrop of increased resorptive possibilities damaged tissue.

The constant presence of pharmaceuticals at all stages of the wound healing process significantly reduces the size of the wound in a short time (usually 3-4 days), reduced trauma to the wound surface due to interoperability gel base and regenerating tissue. Improvement of local and General immunity reduces the healing time of wounds for 1-3 days, except for estopel in maxillofacial surgery in an emergency with a diagnosis of Carbuncle left buccal region. Thrombosis of the angular vein of the person on the left. When applying the General condition of the child hard. From the side of the maxillofacial region has been the complaint of pain and swelling in the cheek and infraorbital areas to the left, infected wound of buccal region with purulent-necrotic detachable, limited mouth opening, up to 1.5 cm, poor food intake. The examination the patient is lethargic, severe pallor of the skin with a bluish tinge, dinamiche. Marked asymmetry of the Central zone of the face due to swelling and infiltration of the soft tissues of the cheek, infraorbital regions with the transition to the lower eyelid on the left. The eye slit is narrowed, the vision is not compromised. Over the infiltrate skin thinning, redness, intense, crease not going palpation causes a sharp pain in the center of the infiltrate in the buccal region has infected wound 2,54,5 cm with a dirty-gray bloom and gaping edges. To the medial corner of the eye traced the tight painful heavy, limiting mouth opening. Bimanual palpation of the area of infiltration applies to the entire thickness of the cheeks and upper lip on the left, on the mucous membrane along the line of closing the teeth are postoperative incision up to 2 cm with swollen, covered with fibrin edges. On extrinsical and culture from a wound on flora and sensitivity to antibiotics. In cavity wounds laid the napkin “ Kreteks D” in the form of a hollow element, inside of which is placed a polyamide tube. To the edges of the wound to maintain a linear plane and prevent them from wrapping medicinal basis of fixed napkin “Kreteks D”. Started radiation carotid sinuses on the right and left infrared laser, as well as through drainage and on the edges of the wound photophoresis for 3 minutes with 3 fields, on a daily basis. On the third day after the start of treatment there was a decrease in pain intensity, improved appetite, the child became more active. Ligation was performed daily with the use of antiseptic solutions (0,5-1% dioksidina, 3% hydrogen peroxide together with furacin and so on). Verified Staphylococcus aureus CFU over 10 million and launched a massive antibacterial therapy taking into account the sensitivity of flora and symptomatic therapy, including tonic, immune-stimulating, thrombolytic effect. In 5 days the wound of buccal region is cleaned with the advent of the demarcation lines on the edges and the development juicy bleeding granulations on the bottom of the wound. Removed the drains. On the area of the strand and wound application laid napkins “Kreteks MEX (Mexidol), photophoresis IR laser for 2 minutes in the course is in biopsies - picture of severe contamination of wounds, necrosis throughout its layers. There was a significant positive trend for 10 days, when the size of the wound decreased to 1.5-2 cm, epithelialization it from the bottom and edges with juicy pink granulation, the strand along the branches of the facial vein barely palpated, mouth opening to 2 see Given the good parameters of wound healing and scarring of the wound overlay secondary joints not shown. Keeping the wound continued to 10 procedures. When the latter takes the smear on flora - growth it is not. The treatment is completed and for 12 hours the patient was discharged for outpatient monitoring.

Example 2.

Patient B., 1939 R. was in maxillofacial surgery with a diagnosis of odontogenic cellulitis of floor of mouth and deep spaces of the neck to the right. On the day of receipt in an emergency produced by the opening and drainage of cellulitis under endotracheal anesthesia. Given the severity of the condition, the patient was taken to the intensive care unit, where he continued mechanical ventilation, antibacterial and detoxification therapy. With the positive dynamics was transferred to the Department of maxillofacial surgery at 2 days after surgery with stable hemodynamics, with the SIDA) on wound podvodburstroy area and neck to the right for 2 days, then Collex M (metronidazole) up to 5 days by the method described above. Experienced reduced pain in the wounds and swallowing, improve well-being and appetite, accelerating the purification using applications napkins “Kreteks MEX and epithelialization of the wound with the formation of smooth, soft scar, not requiring correction.

The proposed method allows to reduce the time of stay of the patient in the hospital, to significantly improve the cosmetic effect, to exclude the possibility of complications.

Method for the treatment of patients with purulent-necrotic diseases of the maxillofacial area, including surgical treatment with the introduction of purulent-necrotic lesion of the bioactive material, the laser irradiation postoperative wounds, characterized in that access to the focus of necrotic lesion and placed in the wound cavity napkin “Kreteks D” or “Kreteks M” in the form of a hollow element, inside of which are placed end-to-end Winternitz drainage, fix it with the cloth to the skin wound, between the edges of the wound stack a second cloth Collex M, forming the wound edges in a linear plane, and carry out irradiation of infrared laser therapeutic dozirovka 2-3 minutes daily until the end of the purulent discharge from the wound, then hold the application wipes “Kreteks MEX region infiltrate with irradiation for 5-10 min until the end of wound healing.

 

Same patents:
The invention relates to medicine and can be used in plastic surgery and dermatology

The invention relates to medicine, namely to gynecology

The invention relates to medicine, namely to gastroenterology

The invention relates to medicine, namely to gastroenterology

The invention relates to medicine and can be used in the treatment of purulent-inflammatory processes in soft tissues and internal organs and allows you to accelerate the phase change of wound healing and healing and to achieve more pronounced cosmetic effect

The invention relates to medical equipment and can be used for correction of functional disorders of man

The invention relates to medicine, namely to Phthisiology

The invention relates to medicine, namely to pulmonology and physiotherapy
The invention relates to medicine, namely to reducing treatment in traumatology and orthopedics, and can be used in patients with arthrosis, osteochondrosis of the spine, herniated intervertebral disc, epicondylitis, bruises, syndrome title, carpal tunnel, etc

FIELD: medicine.

SUBSTANCE: method involves introducing 0.1-0.3 ml of photosensitizing gel preliminarily activated with laser radiation, after having removed neovascular membrane. The photosensitizing gel is based on a viscoelastic of hyaluronic acid containing khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-2% by mass. The photosensitizing gel is in vitro activated with laser radiation having wavelength of 661-666 nm during 3-10 min with total radiation dose being equal to 100-600 J/cm2. The gel is introduced immediately after being activated. To compress the retina, vitreous cavity is filled with perfluororganic compound or air to be further substituted with silicon oil. The operation is ended with placing sutures on sclerotomy and conjunctiva areas. Compounds like chealon, viscoate or hyatulon are used as viscoelastic based on hyaluronic acid. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity.

EFFECT: excluded recurrences of surgically removed neovascular membrane and development of proliferative retinopathy and retina detachment; retained vision function.

3 cl, 5 dwg

FIELD: medicine.

SUBSTANCE: method involves making incision in conjunctiva and Tenon's capsule of 3-4 mm in size in choroid hemangioma projection to sclera 3-4 mm far from limb. Tunnel is built between sclera and Tenon's capsule to extrasclerally introduce flexible polymer magnetolaser implant through the tunnel to the place, the choroid hemangioma is localized, after performing transscleral diaphanoscopic adjustment of choroid hemangioma localization and size, under visual control using guidance beam. The implant has permanent ring-shaped magnet in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 2-3 mTesla units intensity. It is arranged with its north pole turned towards the choroid hemangioma so that extrascleral implant laser radiator disposition. The other end of the implant is sutured to sclera 5-6 mm far from the limb with two interrupted sutures through prefabricated openings. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. 0.1-1% khlorin solution is injected in intravenous bolus dose of 0.8-1.1 mg/kg as photosensitizer and visual control of choroid hemangioma cells fluorescence and fluorescent diagnosis methods are applied. After saturating choroid hemangioma with the photosensitizer to maximum level, transscleral choroid hemangioma laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm with total radiation dose being equal to 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the intraocular neoplasm, repeated laser irradiation of the choroid hemangioma is carried out with radiation dose of 30-60 J/cm2.

EFFECT: enhanced effectiveness of treatment.

4 cl

FIELD: medicine.

SUBSTANCE: method involves creating tunnel between sclera and Tenon's capsule in intraocular neoplasm projection. Intraocular neoplasm localization and size is adjusted by applying transscleral diaphanoscopic examination method. 0.1-0.3 ml of photosensitizing gel based on viscoelastic of hyaluronic acid, selected from group containing chealon, viscoate or hyatulon, is transsclerally introduced into intraocular neoplasm structure using special purpose needle in dosed manner. The photosensitizing gel contains khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-1% by mass. Flexible polymer magnetolaser implant is extrasclerally introduced into the built tunnel in intraocular neoplasm projection zone under visual control using guidance beam. The implant has permanent ring-shaped magnet axially magnetized and producing permanent magnetic field of 3-4 mTesla units intensity, in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The implant is arranged with its north pole turned towards the intraocular neoplasm so that implant laser radiator lens is extrasclerally arranged in intraocular neoplasm projection zone. The implant light guide is sutured to sclera 5-6 mm far from the limb with single interrupted suture. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transscleral intraocular neoplasm laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm. The treatment course being over, the flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen. 0.1-1% khlorin solution as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is additionally intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg and repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2 15-20 min later during 30-90 s.

EFFECT: complete destruction of neoplasm; excluded its further growth.

4 cl

FIELD: medicine.

SUBSTANCE: method involves applying transscleral diaphanoscopic examination method for adjusting intraocular neoplasm localization and size. Rectangular scleral pocket is built 2/3 times as large as sclera thickness which base is turned from the limb. Several electrodes manufactured from a metal of platinum group are introduced into intraocular neoplasm structure via the built scleral pocket. Next to it, intraocular neoplasm electrochemical destruction is carried out in changing electrodes polarity with current intensity of 100 mA during 1-10 min, and the electrodes are removed. Superficial scleral flap is returned to its place and fixed with interrupted sutures. 0.1-2% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transpupillary laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2. the operation is ended with placing sutures on conjunctiva. Platinum, iridium or rhodium are used as the metals of platinum group. The number of electrodes is equal to 4-8. 0.1-1% khlorin solution, selected from group containing photolon, radachlorine or photoditazine, is additionally repeatedly intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm2.

EFFECT: complete destruction of neoplasm; excluded tumor recurrence; reduced risk of tumor cells dissemination.

3 cl, 3 dwg

FIELD: medicine.

SUBSTANCE: the present innovation deals with treating vascular cutaneous neoplasms, such as nevus flammeus and gemangiomas. Light-thermal impact at energy ranged 39-47 J/sq. cm should be performed in two stages, and between them, 2-3 wk after the onset of vascular resistance at the first stage one should perform beta-therapy daily for 2-3 d at single dosage being 20 g. Then, 3 wk later it is necessary to conduct the second stage of light-thermal impact by starting at energy value being 42 J/sq. cm, not less. The method enables to shorten therapy terms due to applying combined method to affect vascular cutaneous neoplasms.

EFFECT: higher therapeutic and cosmetic effect.

1 ex

FIELD: medicine.

SUBSTANCE: method involves intravitreously introducing two electrodes into intraocular neoplasm after carrying out vitrectomy and retinotomy to expose the intraocular neoplasm. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with current intensity of 100 mA during 1-10 min or 10 mA during 10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2.The transformed retina and tumor destruction products are intravitreally removed. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. Another embodiment of the invention involves adjusting position and size of the intraocular neoplasm in trans-scleral diaphanoscopic way. Rectangular scleral pocket is built above the intraocular neoplasm to 2/3 of sclera thickness with its base turned away from limb. Several electrodes are introduced into intraocular neoplasm structure via the built bed. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with the same current intensity in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. Superficial scleral flat is returned to its place and fixed with interrupted sutures. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg after having carried out vitrectomy and retinotomy. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2. The transformed retina and tumor destruction products are intravitreally removed using vitreotome. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. The number of electrodes is equal to 4-8.

EFFECT: reduced risk of metastasizing.

4 cl, 13 dwg

FIELD: medicine.

SUBSTANCE: method involves building tunnel to posterior eyeball pole in inferoexterior and superexterior quadrants. The tunnel is used for implanting flexible polymer magnetolaser implant to the place, the subretinal neovascular membrane is localized. The implant has a permanent magnet shaped as a cut ring and is provided with drug delivery system and a short focus scattering lens of laser radiator connected to light guide. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 5-7 mTesla units intensity. It is arranged with its north pole turned towards sclera at the place of the subretinal neovascular membrane projection with extrascleral arrangement of laser radiator lens membrane being provided in the subretinal neovascular membrane projection area. The other implant end is sutured to sclera 5-6 mm far from the limb via holes made in advance. The implant is covered with conjunctiva and retention sutures are placed thereon. Light guide and drug supply system lead is attached to temple with any known method applied. Drugs are supplied via the implant drug supply system in retrobulbary way in any order. Triombrast is given in the amount of 0,4-0,6 ml and dexamethasone or dexone in the amount of 0,4-0,6 ml during 3-4 days every 12 h. 0.1-1% aqueous solution of khlorin is intravenously introduced at the third-fourth day after setting the implant as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, at a bolus dose of 0.8-1.1 mg/kg. Visual control of subretinal neovascular membrane cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the subretinal neovascular membrane with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at general dose of 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the subretinal neovascular membrane via laser light guide and implant lens, repeated laser irradiation of the subretinal neovascular membrane is carried out with radiation dose of 30-60 J/cm2.

EFFECT: accelerated subretinal edema and hemorrhages resorption; regression and obliteration of the subretinal neovascular membrane; prolonged vision function stabilization.

6 cl

FIELD: medicine.

SUBSTANCE: method involves filling vitreous cavity with perfluororganic compound. Two electrodes manufactured from platinum group metal are intravitreally, transretinally introduced into intraocular neoplasm. Electrochemical destruction is carried out with current intensity of 10-100 mA during 1-10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2 in perfluororganic compound medium. The transformed retina and tumor destruction products are intravitreally removed with perfluororganic compound volume being compensated with its additional introduction. Boundary-making endolasercoagulation of retinotomy area is carried out. The perfluororganic compound is substituted with silicon oil. The operation is ended in placing sutures over sclerotmy areas and over conjunctiva. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity. Platinum, iridium or rhodium are used as the platinum group metals.

EFFECT: complete destruction of neoplasm; reduced dissemination risk.

6 cl, 12 dwg

FIELD: medicine, applicable for stopping of pains of various nature.

SUBSTANCE: the device has a quantum-mechanical oscillator located in a casing, magnet, vessel for medicinal agent and a hollow cylinder. The magnet is installed between the oscillator and the vessel. Positioned in the vessel is a hollow cylinder having through holes on its surface.

EFFECT: quick and absolute anestesia.

2 ex, 1 dwg

FIELD: medicine.

SUBSTANCE: method involves administering laser radiation therapy once a day using low intensity pulsating radiation of wavelength equal to 890nmand power density of 0.03 mW/cm2. Injured organ projection to frontal abdominal wall is exposed to radiation at the first laser therapy stage in two fields acting upon each field for 2 min with radiation pulse succession frequency equal to 80 Hz in applying stable contact-type method. Total treatment dose on two fields is equal to 0.008 J/cm2. The second laser therapy stage begins immediately after having finished the first one in applying radiation along the large intestine path using labile contact-type method in a way that radiation pulse succession frequency equal to 80 Hz is applied first during 1 min and then frequencies of 600, 150 and 300 Hz are applied also during 1 min, respectively. Total treatment dose is equal to 0.032 J/cm2 at the second stage. Total treatment dose is equal to 0.04 J/cm2 at both stages.

EFFECT: enhanced effectiveness in inhibiting dysbacteriosis; reduced frequency of postoperative complications.

Up!